Resize text 
Resize text
The ENCePP Steering Group was established in 2010 to oversee the mid to long-term implementation of the ENCePP project. The Steering Group consists of 16 members and provides a good balance of expertise (regulatory, conduct of pharmacoepidemiological studies, patients, healthcare professionals, ethical issues). Six members of the Steering Group are elected representatives from the ENCePP Plenary. From 2014 onwards the term of service of the Steering Group is three years.
The ENCePP Steering Group defines and safeguards the objectives and principles of ENCePP and decides on operational tasks of the network. The Steering Group is the highest authority of ENCePP and thus is its final decision making body. It acts as adjudicator in case of discrepancies or complaints in the context of the ENCePP network.
For further information, see: 
Mandate of the ENCePP Steering Group
printer-friendly version: 
Composition of ENCePP Steering Group 2017-2019
| No. | Representing | Name | Affiliation |
|---|---|---|---|
1 |
ENCePP |
Vera Ehrenstein |
Department of Clinical Epidemiology, Aarhus University, Denmark |
2 |
ENCePP |
Rosa Gini |
|
3 |
ENCePP |
Teresa Herdeiro | |
4 |
ENCePP |
Olaf Klungel |
|
5 |
ENCePP |
Tom MacDonald (Deputy Chair) |
Medicines Monitoring Unit (MEMO) and Hypertension Research Centre (HRC), University of Dundee, UK |
6 |
ENCePP |
Gianluca Trifirò |
|
7 |
EMA |
Xavier Kurz (Chair) |
European Medicines Agency |
8 |
EMA |
Corinne de Vries |
European Medicines Agency |
9 |
EMA |
Hans-Georg Eichler |
European Medicines Agency |
10 |
HMA |
vacant |
|
11 |
CHMP | Johann Lodewijk Hillege | College ter Beoordeling van Geneesmiddelen, Netherlands |
12 |
COMP | Dinah Duarte | INFARMED - Autoridade Nacional do Medicamento e Produtos de Saúde, Portugal |
13 |
PRAC | Marieke de Bruin | University of Copenhagen, Denmark |
14 |
PCWP | Kathi Apostolidis | ECPC - European Cancer Patient Coalition |
15 |
ISPE | Yola Moride | Faculty of Pharmacy, Université de Montréal, Canada |
16 |
ISoP | Herve Le Louet | Centre de Pharmacovigilance & Information sur le médicament, Hôpital Henri Mondor, Paris, France |
| Observer | EFPIA | Patrice Verpillat | Merck Group, Germany |
Principal Scientific Advisor |
EMA | Giampiero Mazzaglia | European Medicines Agency |
Statistical Advisor |
EMA | Jim Slattery | European Medicines Agency |
| Observer | EMA | Gianmario Candore | European Medicines Agency |
| EMA | European Medicines Agency |
| HMA | Heads of Medicines Agencies |
| CHMP | Committee for Medicinal Products for Human Use |
| COMP | Committee for Orphan Medicinal Products |
| PRAC | Pharmacovigilance Risk Assessment Committee |
| PCWP | EMA Human Scientific Committees' Working Party with Patients' and Consumers' Organisations |
| ISPE | International Society for Pharmacoepidemiology |
| ISoP | International Society of Pharmacovigilance |
| EFPIA | European Federation of Pharmaceutical Industries and Associations |
Composition of Steering Group 2014-2016 Composition of Steering Group 2012-2013
Composition of Steering Group 2010-2011
